Provider views on perioperative steroid use for patients with newly diagnosed pediatric brain tumors
| Autor: | Fatema Malbari, Kristen A. Staggers, Adam S. Levy, Charles G. Minard, Murali Chintagumpala, Howard L. Weiner |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Cancer Research
medicine.medical_specialty Neurology Health Personnel Brain Edema Loading dose Dexamethasone Cerebral edema 03 medical and health sciences Postoperative Complications 0302 clinical medicine Internal medicine Edema medicine Humans Perioperative Medicine Adverse effect Response rate (survey) Brain Neoplasms business.industry Perioperative medicine.disease Oncology 030220 oncology & carcinogenesis Steroids Neurology (clinical) medicine.symptom business 030217 neurology & neurosurgery Hydrocephalus medicine.drug |
| Zdroj: | Journal of Neuro-Oncology. 147:205-212 |
| ISSN: | 1573-7373 0167-594X |
| Popis: | Cerebral edema from brain tumors can cause neurological impairment. Steroids treat edema but with possible adverse effects. We surveyed providers regarding steroid use in newly diagnosed patients with brain tumors to determine if practices are standard or markedly variable. An anonymous voluntary online survey was sent to members of neuro-oncology consortiums. Four clinical scenarios were provided and questions regarding initiation of steroids, type, dose, formulation, and duration were asked. Demographic information was collected. 369 providers received the survey, 76 responded (20.6% response rate). The proportion of providers who would start steroids significantly differed among scenarios (scenario 1 vs 2, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink